{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-138767","form_type":"8-K","ticker":"ENGN","cik":"0001980845","company_name":"enGene Therapeutics Inc.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.516384+00:00","generated_at":"2026-05-29T00:35:31.750588+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"enGene enters $100M ATM equity sale agreement with Jefferies","bullets":["Entered Open Market Sale Agreement with Jefferies for ATM offering of common shares up to $100M.","Jefferies receives up to 3% commission; shares sold under prospectus supplement dated Dec 20, 2024.","Offering not available in Canada and company not obligated to sell any shares.","Agreement terminable by either party; proceeds for general corporate purposes not specified."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-138767","json":"https://secwatch.observer/filing/0000950170-24-138767.json","markdown":"https://secwatch.observer/filing/0000950170-24-138767.md","text":"https://secwatch.observer/filing/0000950170-24-138767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1980845/000095017024138767/0000950170-24-138767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1980845/000095017024138767/engn-20241220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:35:31.750588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}